3- Paediatric Respiratory Flashcards

1
Q

Cough classification

A

Acute
- Infective e.g. viral, bacterial
- Non-infective e.g. foreign body, irritant toxin

Subacute (3-8 weeks)
- Post viral cough
- Pertussis and similar infections
- Children recovering from pneumonia

Chronic
- >8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

causes of acute onset cough

A

1) Respiratory infection

Upper:
- rhinovirus
- coronavirus
- croup
- epiglottis
- pharyngitis

Lower
- pneumonia
- bronchitis
- bronchiolitis

2) Foreign body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

history for chronic cough

A

1) How and when did it start?
2) Nature of cough: wet/ dry/whooping
3) Diurnal variation, triggers of cough, habit stop when sleep
4) Fx
- Atopy
- Smoking
- Contact with TB
5) Associated features
- Wheezing
- Failure to thrive
- Progressive worsening
- Neuromuscular weakness
- Reflux
- Aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

causes of chronic cough

A
  • Persistent bacterial bronchitis (PBB)
  • Recurrent aspiration
  • Bronchiectasis
    o Progression of PBB
    o Recurrent aspiration
    o CF
    PCD
    immune problems
  • Rhinitis
  • Immune problems
  • GORD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

investigations for chronic cough

A

Investigations
- History – history of infection (acute/recurrent), nasal symptoms, failure to thrive, wheeze, response to previous treatments, atopy etc.
- CXR
- Bloods – immune screen (T-cell subsets, antibody response, immunoglobulins), allergy markers (Eosinophils, IgE, sIgE)
- Lung function test if old enough
- swallow assessment- aspiration

2nd line investigations
- Sweat test
- Bronchoscopy
- pH/impedance study
- High Resolution CT
- Nasal brushings- primary ciliary dyskinesia testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protracted bacterial bronchitis Background

A

Persistent bacterial infection in lower airways

  • Presence of wet cough (>4 weeks’ duration)
  • Absence of symptoms or signs (i.e. specific cough pointers) suggestive of other causes
  • Cough resolves following a 2–4-week course of an appropriate oral antibiotic i.e. co-amoxiclav
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

presentation of PBB

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

investigations for PBB

A

Investigations
- History – history of infection (acute/recurrent), nasal symptoms, failure to thrive, wheeze, response to previous treatments, atopy etc.
- CXR
- Bloods – immune screen (T-cell subsets, antibody response, immunoglobulins), allergy markers (Eosinophils, IgE, sIgE)
- Lung function test if old enough

2nd line
- Sweat test
- Bronchoscopy
- pH/impedance study
- High Resolution CT
- Nasal brushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

investigations for PBB

A

Investigations
- History – history of infection (acute/recurrent), nasal symptoms, failure to thrive, wheeze, response to previous treatments, atopy etc.
- CXR
- Bloods – immune screen (T-cell subsets, antibody response, immunoglobulins), allergy markers (Eosinophils, IgE, sIgE)
- Lung function test if old enough

2nd line
- Sweat test
- Bronchoscopy
- pH/impedance study
- High Resolution CT
- Nasal brushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

investigations for PBB

A

Investigations
- History – history of infection (acute/recurrent), nasal symptoms, failure to thrive, wheeze, response to previous treatments, atopy etc.
- CXR
- Bloods – immune screen (T-cell subsets, antibody response, immunoglobulins), allergy markers (Eosinophils, IgE, sIgE)
- Lung function test if old enough

2nd line
- Sweat test
- Bronchoscopy
- pH/impedance study
- High Resolution CT
- Nasal brushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

management of PBB

A
  • sputum culture -> antibiotic therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Children who present with wheezing are diagnosed differently depending on their ….

A

Age

Bronchiolitis <1
- Prodromal
- RSV

Viral wheeze <5
- Prodromal
- Occurs at time of virus

Asthma exacerbation >5
- Doesn’t have to have prodrome
- Can be triggered by infection but also hay fever, cold, exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

general management of wheeze

A

for bronchiolitis
- supportive care (not salbutamol)

for viral induced wheeze and asthma:
- salbutamol
- steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis of wheeze

A
  • Bronchiolitis- self limiting
  • Viral wheeze – you grow out of
  • Asthma – still there after age of 5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Viral Induced Wheeze or Asthma?

A

The distinction between a viral-induced wheeze and asthma is not definitive. Generally, typical features of viral-induced wheeze (as opposed to asthma) are:

  • Presenting before 3 years of age
  • No atopic history
  • Only occurs during viral infections

Asthma can also be triggered by viral or bacterial infections, however it also has other triggers, such as exercise, cold weather, dust and strong emotions. Asthma is historically a clinical diagnosis, and the diagnosis is based on the presence of typical signs and symptoms along with variable and reversible airflow obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Viral induced wheeze background

A
  • Describe an acute wheezy illness caused by viral infections
  • Typically under 3- due to small airways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathophysiology of viral induced wheeze

A
  • When airways encounter virus (RSV or rhino) they develop a small amount of inflammation and oedema -> this restricts the space for air to flow
  • Inflammation also triggers smooth muscles of the airway to constrict
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Presentation of viral induces

A

Evidence of a viral illness (fever, cough and coryzal symptoms) for 1-2 days preceding the onset of:
* Shortness of breath
* Signs of respiratory distress
* Expiratory wheeze throughout the chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

management of viral induced wheeze

A

Same as acutee asthma in children
- Salbutamol
- Oxygen as needed
- Ipratrium if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

asthma background

A
  • Commonest respiratory condition
  • Chronic inflammatory airway disease leading to variable airway obstruction
  • Atopic condition
    o Asthma
    o Eczema
    o Hay fever
    o Food allergies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pathophysiology of asthma

A
  • Smooth muscle in airway is hypersensitive and responds to stimuli by constriction and causing airflow obstruction
  • Bronchoconstriction is reversible with bronchodilators such as inhaled salbutamol
  • Typical triggers
    o Dust
    o Animal
    o Scold air
    o Exercise
    o Smoke
    o Food allergens
    o Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Risk factors for asthma

A
  • Personal/familial history of atopy
  • Inner city environment
  • Obesity
  • Viral infections in early childhood
  • Smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

protective factors for asthma

A

o Vaginal birth
o Increasing sibship

23
Q

Triggers for asthma

A

e.g. exercise, allergen, irritant exposure, change in weather and viral resp infection- cause an inflammatory cascade within the bronchial tree

24
Q

presentation of asthma

A
  • Episodic symptoms with intermittent exacerbations
  • Diurnal variability, typically worse at night and early morning
  • Dry cough with wheeze and shortness of breath
  • Typical triggers
  • A history of other atopic conditions such as eczema, hayfever and food allergies
  • Family history of asthma or atopy
  • Bilateral widespread “polyphonic” wheeze heard by a healthcare professional
  • Symptoms improve with bronchodilators
25
Q

Presentation Indicating a Diagnosis Other Than Asthma

A
  • Wheeze only related to coughs and colds, more suggestive of viral induced wheeze
  • Isolated or productive cough
  • Normal investigations
  • No response to treatment
  • Unilateral wheeze suggesting a focal lesion, inhaled foreign body or infection
26
Q

Investigations for asthma

A

No gold standard criteria. Typically history and examination. Not typically diagnosed until 2 to 3 years old.

2 scenarios
- Low probability of asthma and the child is symptomatic -> refer to a specialist for diagnosis
- If intermediate or high probability asthma -> trial of treatment and if symptoms improve a diagnosis can be made

27
Q

If asthma diagnostic doubt e.g. if low probability of asthma and the child his symptomatic

A

Send to a specialist
Spirometry with reversibility testing (in children aged over 5 years)
- <70% (may be diff in children)
- 12% reversibility = diagnostic of asthma

Direct bronchial challenge test with histamine or methacholine (non-selective muscarinic receptor agonist in PNS) (metacholinergic challenge test)
- Used to help diagnose asthma
- Degree of narrowing measured by spirometer

Fractional exhaled nitric oxide (FeNO)
- Inflammation of the lungs

Peak flow variability
o Measured by keeping a diary of peak flow measurements several times a day for 2 to 4 weeks

28
Q

Reversibility in asthma

A

Bronchodilator reversibility typically involves repeating spirometry testing 20 – 30 mins after administering a dose of bronchodilator (typically Salbutamol 2 x 200mcg puffs, ideally via a large volume spacer). If there is ‘reversible’ airways obstruction, there will be an improvement in the FEV1/FVC ratio.

29
Q

spirometry definitions

A
  • FVC = The volume breathed out during the forced expiration.
  • FEV1 = The volume breathed out during the first second
  • FEV1/FVC = The proportion of the FVC that is breathed out in the first second
  • PEFR = The Peak Expiratory Flow Rate – the gradient of the graph at time 0, which corresponds to the highest rate of flow of air from the lungs.
30
Q

peak flow

A
  • Measures peak expiratory flow rate
  • Simplest test
  • Important role in management of established asthma

Technique
- Advise the patient to take in a deep breath and expel it as rapidly and as forcefully as possible into the meter.
- The very first part is all that matters for this test and it is not necessary to empty the lungs completely.
- Record the best of three tests.
- Continue blows if the two largest are not within 40 L/minute, as the patient is still acquiring the technique.

Interpretation
- Patients peak flow can be compared with listed normal for their age, sex and height
- Patients record peak flow diary – can provide objective warning of clinical deterioration

31
Q

spirometry vs peak flow

A
  • Preferred over Peak flow- can be used for initial confirmation of asthma
  • Calculates FVC and FEV1
  • Can also confirm reversibility in subjects with pre-existing obstruction of airway (after use of bronchodilator)- 12%
32
Q

FeNO

A
  • Measure amount of nitric oxide in breath
  • Increased levels related to lung inflammation and asthma
  • affected by smoking and inhaled corticosteroids
33
Q

CXR

A
  • Normally normal even in severe asthma
  • Not used routinely in assessment of asthma
  • Could be used with atypical history/exam
34
Q

Asthma management

A

Follow BTS/SIGN guidelines
The principles of using the stepwise ladder are to:
1) Start at the most appropriate step for the severity of the symptoms
2) Review at regular intervals based on the severity
3) Step up and down the ladder based on symptoms
4) Aim to achieve no symptoms or exacerbations on the lowest dose and number of treatments

35
Q

asthma management: stewpise approach

A

Step 1 (mild, intermittent asthma)
- Salbutamol (Beta 2-agonist)
- Everyone offered and should be used PRN

Step 2 (if use of salbutamol more than 3 times a week, symptoms more than 3 times a week, waking due to asthma more than once a week)
- Inhaled corticosteroid

Step 3 (if Beta-2 agonist/ inhaled steroid not enough)
Add on:
- Leukotriene receptor antagonist (LTRA- Montelukast) before treatment with a long acting beta 2 agonist (LABA) e.g. salmeterol
- LABA should never be used without concurrent use of inhaled steroid

Step 4 (persistent poor control)
- Add beclomethasone
- And/or theophylline or beta2-agonsit tablet

Step 5
- Continuous or frequent use of oral steroids, maintaining high dose inhaled steroids
- (Referral to resp doctor at step 4-5)
- Omalizumab- option for treating severe persistent allergic IgE mediated asthma

36
Q

Management in specific age groups: Under 5 Years
.

A
  1. Start a short-acting beta-2 agonist inhaler (e.g. salbutamol) as required
  2. Add a low dose corticosteroid inhaler or a leukotriene antagonist (i.e. oral montelukast)
  3. Add the other option from step 2.
  4. Refer to a specialist
37
Q

Management in specific age groups: 5 – 12 Years

A
  1. Start a short-acting beta-2 agonist inhaler (e.g. salbutamol) as required
  2. Add a regular low dose corticosteroid inhaler
  3. Add a long-acting beta-2 agonist inhaler (e.g. salmeterol). Continue salmeterol only if the patient has a good response.
  4. Titrate up the corticosteroid inhaler to a medium dose. Consider adding:
    o Oral leukotriene receptor antagonist (e.g. montelukas)
    o Oral theophylline
  5. Increase the dose of the inhaled corticosteroid to a high dose.
  6. Referral to a specialist. They may require daily oral steroids
38
Q

Managaement in specific age groups: Over 12 Years (Same as Adults)

A
  1. Start a short-acting beta 2 agonist inhaler (e.g. salbutamol) as required
  2. Add a regular low dose corticosteroid inhaler
  3. Add a long-acting beta-2 agonist inhaler (e.g. salmeterol). Continue salmeterol only if the patient has a good response.
  4. Titrate up the corticosteroid inhaler to a medium dose. Consider a trial of an oral leukotriene receptor antagonist (i.e. montelukast), oral theophylline or an inhaled LAMA (i.e. tiotropium).
  5. Titrate the inhaled corticosteroid up to a high dose. Combine additional treatments from step 4, including the option of an oral beta 2 agonist (i.e. oral salbutamol). Refer to specialist.
  6. Add oral steroids at the lowest dose possible to achieve good control under specialist guidance.
39
Q

Inhaled corticosteroids in children

A

Benefits
- Effective medications which work to prevent poorly controlled asthma and asthma attacks which can lead to higher doses of oral steroids being given
- Poorly controlled asthma can lead to more significant impact on growth and development
- Minimal dose always given

Negatives
- Can slightly reduce growth velocity and small reduction in final adult height up to 1cm when used long term (>12 months)
- Oral thrush – wash mouth out

40
Q

Inhaler technique

A

Better technique improves asthma management. Poor technique results in medication in mouth and throat- oral thrush (steroids). Ideally used with a spacer to maximise effectiveness- almost always spacers in paeds (facemask up to 4/5, then mouth piece)

41
Q

MDI technique without a spacer:

A
  • Remove the cap
  • Shake the inhaler (depending on the type)
  • Sit or stand up straight
  • Lift the chin slightly
  • Fully p
  • Make a tight seal around the inhaler between the lips
  • Take a steady breath in whilst pressing the canister
  • Continue breathing for 3 – 4 seconds after pressing the canister
  • Hold the breath for 10 seconds or as long as comfortably possible
  • Wait 30 seconds before giving a further dose
  • Rinse the mouth after using a steroid inhaler
42
Q

MDI technique with a spacer:

A
  • Assemble the spacer
  • Shake the inhaler (depending on the type)
  • Attach the inhaler to the correct end
  • Sit or stand up straight
  • Lift the chin slightly
  • Make a seal around the spacer mouthpiece or place the mask over the face
  • Spray the dose into the spacer
  • Take steady breaths in and out 5 times until the mist is fully inhaled
  • Delivery devices
  • There are different types of inhaler:
43
Q

presentation and classification for acute asthma exacerbation

A

Presentation

  • Progressively worsening shortness of breath
  • Signs of respiratory distress
  • Fast respiratory rate (tachypnoea)
  • Expiratory wheeze on auscultation heard throughout the chest
  • The chest can sound “tight” on auscultation, with reduced air entry
  • A silent chest is an ominous sign. This is where the airways are so tight it is not possible for the child to move enough air through the airways to create a wheeze. This might be associated with reduce respiratory effort due to fatigue.
    o A less experienced practitioner may think because there is no respiratory distress and no wheeze the child is not as unwell, however in reality this a silent chest is life threatening.

ABGs not very commonly used in acute management

44
Q

Management
Mild asthmas exacerbation cases

A

Can be managed as outpatient with regular salbutamol inhalers via spacer (4-6 puffs every 4 hours)

45
Q

management of mod to severe asthma exacerbation

A

Require a stepwise approach working upwards until control is achieved:
1. ABCDE
2. Oxygen (aiming for above 94%)
3. Bronchodilation
- Salbutamol inhalers (beta-2 agonist) via a spacer device: starting with 10 puffs every 2 hours
- Nebulisers with salbutamol
- Nebulised ipratropium bromide (anti-muscarinic)
4. Oral prednisone (e.g. 1mg per kg of body weight once a day for 3 days)
5. IV hydrocortisone
6. IV magnesium sulphate
7. IV salbutamol
8. IV aminophylline
9
If you haven’t got control by this point the situation is very serious. Call an anaesthetist and the intensive care unit. They may need intubation and ventilation. This call should be made earlier to give the best chance of successfully intubating them before the airway becomes too constricted.

46
Q

stepping down from salbutamol

A
  • Review child prior to next dose of bronchodilator and look for evidence of cyanosis, tracheal tug, subcostal recession, hypoxia, wheeze
  • A typical step down regime of inhaled salbutamol is 10 puffs 2 hourly then 10 puffs 4 hourly then 6 puffs 4 hourly then 4 puffs 6 hourly.
  • Consider monitoring serum potassium if on high dose of salbutamol (causes K+ to be absorbed from the blood into the cells
47
Q

when can be a child be discharged after admission due to asthma exacerbation

A

Can be discharged when child is well on 6 puffs 4 hourly of salbutamol.

48
Q

Reducing regime of salbutamol to continue at home:

A
  • 6 puffs 4 hourly for 48 hours then
  • 4 puffs 6 hourly for 48 hours then
  • 2-4 puffs as required.

Other steps
* Finish the course of steroids if these were started (typically 3 days total)
* Provide safety-net information about when to return to hospital or seek help
* Check inhaler technique
* Provide an individualised written asthma action plan

49
Q

Bronchiolitis
Background

A

Bronchiolitis describes inflammation and infection in the bronchioles, the small airways of the lungs.
- Usually caused by respiratory syncytial virus (RSV)
- Very common in winter
- <1 year most common (<6 months)
- Rarely diagnosed in those >2 yo
- Children who have bronchiolisits more likely to have viral induced wheeze during childhood

50
Q

pathophysiology of bronchiolitis

A
  • When a virus affects the airways of adults, the swelling and mucus are proportionally so small that it has little noticeable effect on breathing.
  • The airways of infants are very small to begin with, and when there is even the smallest amount of inflammation and mucus in the airway it has a significant effect on the infants ability to circulate air to the alveoli and back out.
  • This causes the harsh breath sounds, wheeze and crackles heard on auscultation when listening to a bronchiolitic baby’s chest.
51
Q

Course of RSV infection

A
  • Usually starts with URTI with coryzal symptom
  • Half get better spontaneously
  • The other half develop chest symptoms over the first 1-2 days following the onset of coryzal symptoms
    o Worse on day 3 or 4
    o Symptoms last 7-10 days and most recover within 2-3 weeks
52
Q

presentation of bronchiolitis

A
  • Coryzal symptoms. These are the typical symptoms of a viral upper respiratory tract infection: running or snotty nose, sneezing, mucus in throat and watery eyes.
  • Signs of respiratory distress
  • Dyspnoea (heavy laboured breathing)
  • Tachypnoea (fast breathing)
  • Poor feeding
  • Mild fever (under 39ºC)
  • Apnoeas are episodes where the child stops breathing
  • Wheeze and crackles on auscultation
53
Q

management of mild bronchiolitis

A

Manage at home – symptomatic control

54
Q

Bronchiolitis: reasons for admission

A
  • Aged under 3 months or any pre-existing condition such as prematurity, Downs syndrome or cystic fibrosis
  • 50 – 75% or less of their normal intake of milk
  • Clinical dehydration
  • Respiratory rate above 70
  • Oxygen saturations below 92%
  • Moderate to severe respiratory distress, such as deep recessions or head bobbing
  • Apnoea’s
  • Parents not confident in their ability to manage at home or difficulty accessing medical help from home
55
Q

Bronchiolitis: principles of hospital management

A
  • Ensuring adequate intake
    –> NG tube
    –> IV fluids
    –> Avoid overfeeding as a full stomach restricts breathing
  • Saline nasal drops and suctioning
  • Supplementary oxygen is <92% (NOT SALBUTAMOL)
  • Ventilatory support if required
56
Q

ventilatory support for bronchiolitis

assess

A
  1. High-flow humified oxygen via tight nasal cannula e.g. Airvo or Optiflow
    - Oxygen and air with added pressure
    - Prevents airway from collapsing by adding positive end-expiratory pressure
  2. Continuous positive airway pressure (CPAP)
    - Involves sealed nasal cannula that performs in a similar way to Airvo or Optiflow
    - Delivers higher and more controlled pressures
  3. Intubation and ventilation
    - Endotracheal tube inserted into trachea for fully controlled ventilation